TABLE 2.
Variable | 1 week prior | Post-flight | Invictus Games | 1 week post | ||||
M | SD | M | SD | M | SD | M | SD | |
IG Group | ||||||||
S-IgA Secretion Rate (μg/mL/min∼15 h) | 715.97 | 824.32 | 830.53 | 804.61 | 595.16 | 500.61 | 707.56 | 518.62 |
Cortisol Concentration (μg/mL∼15 h) | 4.26 | 6.21 | 5.44 | 5.53 | 5.63 | 6.31 | 2.41 | 1.37 |
URTI symptom severity | 0.89 | 2.01 | 0.94 | 2.15 | 0.38 | 1.01 | 0.35 | 1.03 |
URTI symptom duration (days) | 0.15 | 0.36 | 1.00 | 1.98 | 0.58 | 1.50 | 0.44 | 0.86 |
CON Group | ||||||||
S-IgA Secretion Rate (μg/mL/min∼15 h) | 529.12 | 207.69 | 583.54 | 318.09 | 687.16 | 452.66 | 628.74 | 330.21 |
Cortisol Concentration (μg/mL) | 1.81 | 0.63 | 2.81 | 1.85 | 2.13 | 1.21 | 2.42 | 1.18 |
URTI symptom severity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
URTI symptom duration (days) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
S-IgA Secretion Rate (μg/mL/min∼15 h) refers to S-IgA exposure across the day and was calculated using AUCg; Cortisol concentration (μg/mL/min∼15 h) refers to cortisol exposure across the day and was calculated using AUCg; URTI symptom severity was calculated using total symptom scores across the study period and averaged across participants; URTI symptom duration was calculated using total days reported across the study period and averaged across participants.